Infectologia
Diretrizes | Tratamento de infecções recorrentes de trato urinário em mulheres.
19 Mai, 2022 | 13:07hAtualização clínica da COVID-19 para o médico emergencista: parada cardíaca dentro e fora do ambiente hospitalar.
18 Mai, 2022 | 17:01hConteúdos relacionados:
Estudo RECOVERY | Por questões de segurança, o recrutamento de pacientes com Covid-19 apresentando hipóxia sem oxigênio ou recebendo oxigênio simples para doses mais altas de corticosteroides foi encerrado.
18 Mai, 2022 | 17:00hEstudo de coorte | Trombose venosa ou arterial e mortes em casos de COVID-19.
18 Mai, 2022 | 16:58hComentário convidado: Risk of arterial and venous thromboses after COVID-19 – The Lancet Infectious Diseases
Comunicado de imprensa: COVID-19’s high blood clot risk – University of Oxford
Comentário no Twitter
Clots with Covid: Multi-national report of over 900,000 people indicates propensity of risk for arterial and venous thrombi is in men, with increasing age, and association with fatalities (4-fold in non-hospitalized) https://t.co/muGnDld4Um pic.twitter.com/6bLiHPLInm
— Eric Topol (@EricTopol) May 13, 2022
Sob licença de Creative Commons Attribution (CC BY 4.0)
Estudo de coorte | Risco de morte e reinternação não planejada após alta hospitalar de internação por COVID-19.
18 Mai, 2022 | 16:56hComentário: Study: Readmission rate for COVID-19 is 11% – CIDRAP
Estudo randomizado | Antibioticoprofilaxia de longa duração na amputação de membro inferior.
18 Mai, 2022 | 16:49hExtended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial – British Journal of Surgery (link para o resumo – $ para o texto completo)
Comentário no Twitter
In the May issue of BJS: Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial https://t.co/2H0TthufvZ @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/taSa4Caibn
— BJS (@BJSurgery) April 30, 2022
Comentário de estudo | Antibióticos para pneumonia pediátrica: menos pode ser suficiente?
18 Mai, 2022 | 16:42hAntibiotics for Pediatric Pneumonia: Might Less Be Enough? – Annals of Emergency Medicine
Conteúdos relacionados:
Treatment of UTIs in Infants <2 Months: A Living Systematic Review – Hospital Pediatrics
Estudo randomizado | Efeito da posição prona na entubação endotraqueal de pacientes com COVID-19 e insuficiência respiratória aguda.
17 Mai, 2022 | 12:13hConteúdos relacionados:
RCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv
Comentário no Twitter
In this trial, in patients with acute hypoxemic respiratory failure from #COVID19, prone positioning, compared with usual care without prone positioning, did not significantly reduce endotracheal intubation at 30 days. https://t.co/1RyYRtcrYj
— JAMA (@JAMA_current) May 15, 2022
Estudo randomizado | Comparação de antibioticoterapia por 8 vs. 15 dias para pneumonia por Pseudomonas aeruginosa associada a ventilador mecânico em adultos.
17 Mai, 2022 | 12:07hComparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial – Intensive Care Medicine (artigo gratuito aqui)
Comentário no Twitter
🧫 8 vs 15 days ABT for Pseudomonas aeruginosa VAP in adults, iDIAPASON RCT: no differences in composite or separate outcomes (90-day mortality/VAP recurrence) between short & long duration treatment.
📢 @yourICM ground-breaking release #LIVES40 #FOAMcc
🖇 https://t.co/LfoUWxCkkl pic.twitter.com/XaWkQ5R6wT— Intensive Care Medicine (@yourICM) May 13, 2022
Estudo de caso-controle e teste negativo | Associação entre vacinação prévia com BNT162b2 contra COVID-19 e infecção sintomática por SARS-CoV-2 em crianças e adolescentes durante a predominância da variante Ômicron.
17 Mai, 2022 | 12:04hEstudo relacionado: Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant – JAMA
Editorial: Protecting Children Against Omicron – JAMA
Comentário no Twitter (fio – clique para saber mais)
This new JAMA study is worth discussing. It found that, this winter, vax effectiveness in 12-15 yos dropped to 0% after 3-5 months & vaccinated were MORE likely to test+ at month 7. May be confounded (see🧵)
But I don't see this as good reason for boostershttps://t.co/zpkIDdZhnn pic.twitter.com/bxAIDmiR8s— Tracy Høeg, MD, PhD (@TracyBethHoeg) May 14, 2022


